TITLE

Bayer third-quarter profit beats analyst estimates

PUB. DATE
December 2006
SOURCE
Chemical Business;Dec2006, Vol. 20 Issue 12, p69
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the third-quarter profit of drug manufacturer Bayer AG declined less than analysts estimated and increased the earnings forecast for its pharmaceuticals unit. It is said that there was a 35 percent decline in net income while sales increased by 26 percent to 7.78 billion euros. To reduce expenses by 700 million euros a year to counter higher costs of raw materials and decline profit of crop-science unit, the company will close sites in the U.S.
ACCESSION #
23789177

 

Related Articles

  • BAYER AG's (Leverkusen DEU) third-quarter profit more than doubled as sales rose in emerging markets and a cost-cutting program announced last year began to take effect.  // MondayMorning;10/31/2011, Vol. 19 Issue 39, p1 

    The article informs that Leverkusen, Germany-based Bayer AG has doubled its profit from the estimated one due to the increase in sales from 285 million euros to 642 million euros in 2011. As stated, Bayer AG is focusing on the sale of the chemical products in 2012 as it was not up to the...

  • CORPORATE.  // MondayMorning;11/4/2013, Vol. 21 Issue 40, p2 

    This section offers business news briefs as of November 4, 2013. Drug firm Pfizer raised its full-year forecast to 2.20 dollars a share after the company beat analysts' estimates on its third-quarter 2013 profit. A drop by 31 percent was seen in pharmaceutical company AstraZeneca's third-quarter...

  • Cost savings lift Ter Beke 2014 earnings despite sales slide. Askew, Katy // Aroq - Just-Food.com (Global News);3/2/2015, p6 

    The article presents a reprint of the article "Cost savings lift Ter Beke 2014 earnings despite sales slide," by Katy Askew, which was published on the website www.just-food.com on February 27, 2015. Topics include the growth in earnings of Ter Beke, a meals-to-meat group, in 2014 despite a...

  • Bayer to shut Houston polychloroprene.  // Chemical Week;10/8/1997, Vol. 159 Issue 38, p7 

    Reports on the plan of Bayer company to close its Houston polychloroprene facility and consolidate production at Dormagen, Germany. Aims of the company for such reorganization plan; Capacity of the Dormagen unit per year.

  • Bayer to Close Brazilian Unit.  // Chemical Market Reporter;2/4/2002, Vol. 261 Issue 5, p2 

    Reports on the plan of Bayer AG to close its thermoplastics plant in Camacari, Brazil. Reasons for closing the plant; Jobs affected by the closure.

  • Monro makes double-digit Q2 income gains.  // Tire Business;11/10/2014, Vol. 32 Issue 16, p42 

    The article focuses on the double-digit net income gains of Monro Muffler Brake Inc., an automotive service company, for the second quarter (Q2) of 2014 with 7.8% higher sales. Topics include the lower demand for maintenance services and brakes, the role of acquisitions and cost control on the...

  • Survive, compete and prosper. Tarry, Chris // Airline Business;Apr2004, Vol. 20 Issue 4, p66 

    Examines the effectiveness of the airline industry in controlling costs. Basic aims of businesses; Earnings forecast for the industry in 2004.

  • Bayer Shutdown Disrupts PC Market. McElligott, Suzanne // Chemical Week;6/14/2000, Vol. 162 Issue 23, p10 

    Deals with the shutdown of Bayer's polycarbonate (PC) unit at Baytown, Texas due to an electrical fire. Plant capacity; Effects on the contracted deliveries of PC; Impact of the shutdown on the PC market.

  • Bayer closings will cost 1,800 jobs. Esposito, Frank // Plastics News;8/13/2001, Vol. 13 Issue 24, p3 

    Reports on the plans of Bayer AG to close 15 polymer plants worldwide by 2005. Jobs to be affected by the plans; Savings from the plant closure.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics